首页> 中文期刊> 《山东医药》 >2009年流行性甲型H1N1流感重症肺炎患儿血清肺表面活性蛋白A、B、C、D的变化

2009年流行性甲型H1N1流感重症肺炎患儿血清肺表面活性蛋白A、B、C、D的变化

         

摘要

Objective To explore the alterations of pulmonary surfactant protein-A, B, C and D in serum in children with severe pneumonia caused by 2009 pandemic H1N1 influenza virus. Method Serum pulmonary surfactant protein-A, B, C and D were measured in 8 severe H1N1 pneumonia children and 20 healthy children with ELISA as well as peripheral white blood cells, prealbumin and albumin. Results Serum levels of pulmonary surfactant protein-A, B, C and D in severe H1N1 pneumonia children were significantly increased compared with healthy ones. The severe pneumonia children' s white blood cells, prealbumin and albumin were greatly decreased, but D-dimer was significantly higher than that in healthy children. Conclusion Serum pulmonary surfactant protein-A, B, C and D may be used as valuable biomarkers for the e-valuation of lung injury and its severity in children with severe H1N1 pneumonia.%目的 探讨流行性甲型H1N1流感(简称甲流)重症肺炎患儿肺表面活性蛋白A、B、C、D在血清含量变化的特点,寻找肺组织损伤的生化指标.方法 采用ELISA方法检测8例甲流重症肺炎患儿(甲流组)和20例健康儿童(对照组)血清肺表面活性蛋白A、B、C、D含量,同时化验前白蛋白和白蛋白等.结果 甲流组血清肺表面活性蛋白A、B、C、D含量高于对照组(P均<0.05);外周血白细胞、血浆前白蛋白、白蛋白等低于对照组(P均<0.05);二聚体高于对照组(P<0.05).结论 甲流重症肺炎患儿血清肺表面活性蛋白A、B、C、D含量可作为肺组织损伤严重程度的检验指标.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号